25 May 2013
Keywords: biowa, licenses, potelligent, technology, novartis, usa-based, wholly-owned
Article | 16 June 2008
USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko Kogyo, says that it has licensed its POTELLIGENT technology to Swiss ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
24 May 2013
© 2013 thepharmaletter.com